Secukinumab Provides Greater Skin Clearance and Improvement in Skin-Related Quality of Life Than Ustekinumab for Biologic-Naive Patients With Psoriasis: Results From the CLEAR 52-Week Study

Document Type

Abstract

Publication Date

June 2017

Journal Title

Journal of the American Academy of Dermatology

Department

Dermatology

Share

COinS